Application 210132

Type
NDA
Sponsor
THERAPEUTICSMD INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BIJUVAESTRADIOL; PROGESTERONECAPSULE;ORAL1MG;100MGYesYes
002BIJUVAESTRADIOL; PROGESTERONECAPSULE;ORAL0.5MG;100MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50261-211Bijuvaestradiol and progesteroneTherapeuticsMD, Inc.NDACurrent
50261-211Bijuvaestradiol and progesteroneTherapeuticsMD, Inc.NDACurrent
50261-211Bijuvaestradiol and progesteroneTherapeuticsMD, Inc.NDACurrent
50261-211Bijuvaestradiol and progesteroneTherapeuticsMD, Inc.NDACurrent
50261-211Bijuvaestradiol and progesteroneTherapeuticsMD, Inc.NDACurrent
50261-211Bijuvaestradiol and progesteroneTherapeuticsMD, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85026SUPPL 2026-02-12
85022SUPPL 2026-02-12
77544SUPPL 2024-02-16
77531SUPPL 2024-02-16
69799SUPPL2021-12-29
69797SUPPL2021-12-29
67908SUPPL2021-06-28
67907SUPPL2021-06-28
67894SUPPL2021-06-24
67893SUPPL2021-06-24
67892SUPPL2021-06-24
58928ORIG2019-06-03
56188ORIG2018-10-30
56150ORIG2018-10-29